Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-066727

CONCERT PHARMACEUTICALS, INC. · CNCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Period of report
Aug 14, 2015
Accepted (ET)
Aug 18, 2015 · 7:59 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Aug 14, 2015S61,684$16.32D388,538ISee Footnote
Common StockF1,F3Aug 14, 2015S3,316$16.32D20,890ISee Footnote
Common StockF1,F4Aug 14, 2015S63,596$16.32D400,581ISee Footnote
Common StockF1,F5Aug 14, 2015S1,404$16.32D8,845ISee Footnote
Common StockF2Aug 18, 2015S298,929$15.70D89,609ISee Footnote
Common StockF3Aug 18, 2015S16,071$15.70D4,819ISee Footnote
Common StockF4Aug 18, 2015S308,195$15.70D92,386ISee Footnote
Common StockF5Aug 18, 2015S6,805$15.70D2,040ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Following the transaction reported in this Form 4, Wilfred Jaeger, as a director of the Issuer, will remain subject to Section 16.